Literature DB >> 18456958

Paul Ehrlich: founder of chemotherapy.

Stefan H E Kaufmann.   

Abstract

Mesh：

Year:  2008        PMID： 18456958     DOI： 10.1038/nrd2582

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  17 in total

1.  The contribution of Paul Ehrlich to histochemistry: a tribute on the occasion of the centenary of his death.

Authors:  Igor Buchwalow; Werner Boecker; Markus Tiemann
Journal:  Virchows Arch       Date:  2014-10-31       Impact factor: 4.064

2.  Metal Complexes for Therapeutic Applications.

Authors:  Johannes Karges; Ryjul W Stokes; Seth M Cohen
Journal:  Trends Chem       Date:  2021-04-14

Review 3.  The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize.

Authors:  Fèlix Bosch; Laia Rosich
Journal:  Pharmacology       Date:  2008-08-05       Impact factor: 2.547

Review 4.  The evolving role of chemical synthesis in antibacterial drug discovery.

Authors:  Peter M Wright; Ian B Seiple; Andrew G Myers
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-02       Impact factor: 15.336

Review 5.  Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.

Authors:  Shao-Hua Yang; Wenjun Li; Nathalie Sumien; Michael Forster; James W Simpkins; Ran Liu
Journal:  Prog Neurobiol       Date:  2015-11-18       Impact factor: 11.685

Review 6.  Discovery of small molecule cancer drugs: successes, challenges and opportunities.

Authors:  Swen Hoelder; Paul A Clarke; Paul Workman
Journal:  Mol Oncol       Date:  2012-03-03       Impact factor: 6.603

7.  Tinnitus: network pathophysiology-network pharmacology.

Authors:  Ana B Elgoyhen; Berthold Langguth; Sven Vanneste; Dirk De Ridder
Journal:  Front Syst Neurosci       Date:  2012-01-25

8.  A Numbers Game: Ribosome Densities, Bacterial Growth, and Antibiotic-Mediated Stasis and Death.

Authors:  Bruce R Levin; Ingrid C McCall; Véronique Perrot; Howard Weiss; Armen Ovesepian; Fernando Baquero
Journal:  mBio       Date:  2017-02-07       Impact factor: 7.867

9.  Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applications.

Authors:  Mingzhu Zhao; Qiang Zhou; Wanghao Ma; Dong-Qing Wei
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-02       Impact factor: 2.629

10.  Dual targeting of the cancer antioxidant network with 1,4-naphthoquinone fused Gold(i) N-heterocyclic carbene complexes.

Authors:  R McCall; M Miles; P Lascuna; B Burney; Z Patel; K J Sidoran; V Sittaramane; J Kocerha; D A Grossie; J L Sessler; K Arumugam; J F Arambula
Journal:  Chem Sci       Date:  2017-07-21       Impact factor: 9.825
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.